PortfoliosLab logoPortfoliosLab logo
TGTX vs. MSTR
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

TGTX vs. MSTR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in TG Therapeutics, Inc. (TGTX) and Strategy Inc (MSTR). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, TGTX achieves a 37.37% return, which is significantly higher than MSTR's -16.29% return. Over the past 10 years, TGTX has underperformed MSTR with an annualized return of 19.05%, while MSTR has yielded a comparatively higher 21.08% annualized return.


TGTX

1D
1.97%
1M
-4.46%
YTD
37.37%
6M
32.83%
1Y
2.22%
3Y*
14.25%
5Y*
1.88%
10Y*
19.05%

MSTR

1D
5.61%
1M
-32.19%
YTD
-16.29%
6M
-30.75%
1Y
-66.03%
3Y*
65.16%
5Y*
19.92%
10Y*
21.08%
*Multi-year figures are annualized to reflect compound growth (CAGR)

TGTX vs. MSTR - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
TGTX
TG Therapeutics, Inc.
37.37%-0.96%76.23%44.38%-37.74%-63.48%368.65%170.73%-50.00%76.34%
MSTR
Strategy Inc
-16.29%-47.53%358.54%346.15%-74.00%40.13%172.42%11.65%-2.70%-33.49%

Correlation

The correlation between TGTX and MSTR is 0.27, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.27

Correlation (3Y)
Calculated over the trailing 3-year period

0.23

Correlation (5Y)
Calculated over the trailing 5-year period

0.33

Correlation (10Y)
Calculated over the trailing 10-year period

0.31

Correlation (All Time)
Calculated using the full available price history since May 4, 2010

0.26

The correlation between TGTX and MSTR shifts across timeframes, from 0.23 (3 years) to 0.33 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

TGTX:

$6.55B

MSTR:

$42.47B

EPS

TGTX:

$2.87

MSTR:

-$40.19

PS Ratio

TGTX:

9.40

MSTR:

79.74

PB Ratio

TGTX:

11.24

MSTR:

1.16

Total Revenue (TTM)

TGTX:

$700.35M

MSTR:

$490.47M

Gross Profit (TTM)

TGTX:

$581.54M

MSTR:

$334.08M

EBITDA (TTM)

TGTX:

$156.88M

MSTR:

$466.93M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

TGTX vs. MSTR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TGTX
TGTX Risk / Return Rank: 4343
Overall Rank
TGTX Sharpe Ratio Rank: 4444
Sharpe Ratio Rank
TGTX Sortino Ratio Rank: 4141
Sortino Ratio Rank
TGTX Omega Ratio Rank: 4141
Omega Ratio Rank
TGTX Calmar Ratio Rank: 4444
Calmar Ratio Rank
TGTX Martin Ratio Rank: 4343
Martin Ratio Rank

MSTR
MSTR Risk / Return Rank: 88
Overall Rank
MSTR Sharpe Ratio Rank: 66
Sharpe Ratio Rank
MSTR Sortino Ratio Rank: 55
Sortino Ratio Rank
MSTR Omega Ratio Rank: 77
Omega Ratio Rank
MSTR Calmar Ratio Rank: 88
Calmar Ratio Rank
MSTR Martin Ratio Rank: 1313
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TGTX vs. MSTR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for TG Therapeutics, Inc. (TGTX) and Strategy Inc (MSTR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


TGTXMSTRDifference
Sharpe ratioReturn per unit of total volatility

+0.98

Sortino ratioReturn per unit of downside risk

+2.08

Omega ratioGain probability vs. loss probability

1.05

0.82

+0.23

Calmar ratioReturn relative to maximum drawdown

0.07

-0.86

+0.93

Martin ratioReturn relative to average drawdown

0.12

-1.27

+1.38

TGTX vs. MSTR - Sharpe Ratio Comparison

The current TGTX Sharpe Ratio is 0.05, which is higher than the MSTR Sharpe Ratio of -0.94. The chart below compares the historical Sharpe Ratios of TGTX and MSTR, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


TGTXMSTRDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.05

-0.94

+0.98

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.02

0.22

-0.20

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.22

0.29

-0.07

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.05

0.12

-0.17

Drawdowns

TGTX vs. MSTR - Drawdown Comparison

The maximum TGTX drawdown since its inception was -99.52%, roughly equal to the maximum MSTR drawdown of -99.86%. Use the drawdown chart below to compare losses from any high point for TGTX and MSTR.


Loading charts...

Drawdown Indicators


TGTXMSTRDifference

Max Drawdown

Largest peak-to-trough decline

-99.52%

-99.86%

+0.34%

Max Drawdown (1Y)

Largest decline over 1 year

-33.76%

-76.53%

+42.77%

Max Drawdown (3Y)

Largest decline over 3 years

-75.69%

-77.42%

+1.73%

Max Drawdown (5Y)

Largest decline over 5 years

-90.75%

-84.11%

-6.64%

Max Drawdown (10Y)

Largest decline over 10 years

-93.19%

-89.27%

-3.92%

Current Drawdown

Current decline from peak

-82.46%

-73.15%

-9.31%

Average Drawdown

Average peak-to-trough decline

-91.46%

-86.47%

-4.99%

Ulcer Index

Depth and duration of drawdowns from previous peaks

19.61%

52.19%

-32.58%

Volatility

TGTX vs. MSTR - Volatility Comparison

The current volatility for TG Therapeutics, Inc. (TGTX) is 12.21%, while Strategy Inc (MSTR) has a volatility of 21.43%. This indicates that TGTX experiences smaller price fluctuations and is considered to be less risky than MSTR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


TGTXMSTRDifference

Volatility (1M)

Calculated over the trailing 1-month period

12.21%

21.43%

-9.22%

Volatility (6M)

Calculated over the trailing 6-month period

33.01%

56.80%

-23.79%

Volatility (1Y)

Calculated over the trailing 1-year period

46.28%

70.82%

-24.54%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

87.69%

90.87%

-3.18%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

86.86%

73.77%

+13.09%

Dividends

TGTX vs. MSTR - Dividend Comparison

Neither TGTX nor MSTR has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

TGTX vs. MSTR - Financials Comparison

This section allows you to compare key financial metrics between TG Therapeutics, Inc. and Strategy Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00M200.00M20222023202420252026
204.92M
124.30M
(TGTX) Total Revenue
(MSTR) Total Revenue
Values in USD except per share items

Frequently Asked Questions


TGTX and MSTR have a correlation of 0.27, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

MSTR has higher volatility (21.43%) compared to TGTX (12.21%). In terms of maximum drawdown, TGTX dropped -99.52% vs MSTR's -99.86%.

TGTX currently has the higher Sharpe Ratio (0.05 vs -0.94), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for TGTX and MSTR

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer